DXR logo

Daxor Corporation Stock Price

NasdaqCM:DXR Community·US$72.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

DXR Share Price Performance

US$12.40
5.17 (71.51%)
US$12.40
5.17 (71.51%)
Price US$12.40

DXR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
3 Rewards

Daxor Corporation Key Details

US$66.3k

Revenue

US$0

Cost of Revenue

US$66.3k

Gross Profit

-US$1.7m

Other Expenses

US$1.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.31
100.00%
2,710.84%
0.7%
View Full Analysis

About DXR

Founded
1971
Employees
n/a
CEO
Michael Feldschuh
WebsiteView website
www.daxor.com

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Recent DXR News & Updates

Recent updates

No updates